BROOKFIELD, Wis., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Connecture, Inc. (Nasdaq:CNXR), a provider of web-based information systems used to create health insurance marketplaces, today announced financial results for the quarter ended June 30, 2016.
“Our second quarter was highlighted by new customer additions with impressive brand name logos, client expansions with several existing relationships and execution of a critical go-live on our new platform” remarked Jeff Surges, President & CEO of Connecture. “However, our financial performance in the second quarter fell short of our expectations as portions of our business undertake transitions that are taking longer than originally expected. While we are encouraged with our progress during this time to materially strengthen our core offerings and capabilities, along with completing the retooling of our go-to-market approach and sales organization, we have more work to do before our revenue growth and profitability will reach our targeted levels. We are confident that our current initiatives bode well for our future, but our expectations are more conservative for the remainder of 2016.”
Second Quarter 2016 Financial Results
- Total revenue was $18.7 million, compared to $23.4 million in the second quarter of 2015, representing a year-over-year decline of 20%. Excluding revenue headwinds from our Enterprise/State segment, which declined by $3.0 million in the second quarter of 2016 compared to the second quarter of 2015, as well as the impact of $3.6 million of non-recurring revenue recognized in the second quarter of 2015 from two terminated health plan customers, revenue in the second quarter of 2016 increased by approximately 12%, compared to the second quarter of 2015.
- Gross margin was $5.1 million, or 27% of total revenue, compared to $9.4 million or 40% of total revenue in the second quarter of 2015. Adjusted gross margin was $6.2 million, or 33% of total revenue, compared to $10.6 million, or 45% of total revenue, in the second quarter of 2015. Gross margin and adjusted gross margins for the second quarter of 2016 were negatively impacted by $0.6 million of one-time costs associated with the integration of the ConnectedHealth acquisition completed during the quarter, the decrease in revenues associated with the Enterprise/State segment, and also by an increase in outside contractor costs incurred in the second quarter of 2016 related to certain of our Enterprise/Commercial segment customers. We expect the outside contractor costs to decline in the second half of the year, improving our gross margins.
- Loss from operations was ($7.2) million, compared to an operating loss of ($2.8) million in the second quarter of 2015.
- Net loss was ($9.9) million, compared to net loss of ($4.3) million in the second quarter of 2015, and includes $1.9 million of expense related to the extinguishment and refinancing of our debt in the second quarter of 2016.
- Adjusted EBITDA was ($5.5) million, compared to Adjusted EBITDA of ($0.4) million in the second quarter of 2015. Adjusted EBITDA for the second quarter of 2016 was impacted by $1.1 million of one-time severance, integration and acquisition costs related to the ConnectedHealth acquisition.
- Cash and cash equivalents totaled $19.0 million and net debt totaled $16.4 million at June 30, 2016, compared to $0.2 million and $49.4 million, respectively, at March 31, 2016.
- Cash used in operations for the three months ended June 30, 2016 was $10.0 million, compared to $7.0 million for the same period last year. As previously noted, the second quarter of 2016 included approximately $0.4 million of cash costs associated with the ConnectedHealth acquisition that closed during the quarter. In addition, we used more cash for working capital needs in the current year period primarily due to the timing of certain contractual billing milestones.
Recent Business Highlights
- Notable new customers added during the second quarter include: AARP Services Inc., ConnectiCare, Inc., OrchestraRx, League of California Cities and Indiana University Health Plans, Inc.
- Notable customer renewals and expansions completed during the quarter include: OptumRx, Prime Therapeutics, BCBS of Massachusetts, and BCBS of Michigan.
- During the second quarter we successfully completed the first phase of our platform launch with USAA, which will add incremental revenue in the second half of the year.
- Total contracted backlog at June 30, 2016 was $95.7 million, compared to $94.0 million at March 31, 2016 and $85.5 million at June 30, 2015. The sequential increase from March 31, 2016, was primarily due to increased sales activity during the quarter that is reflective of the seasonality of our selling activities.
- On June 7, 2016, we announced the closing of the ConnectedHealth acquisition which provides us new software solutions to accelerate consumer engagement and other product lines within the Broker space.
Connecture is revising its full year 2016 guidance for total revenues and adjusted EBITDA as indicated below:
- Total revenue is expected to be in the range of $85.0 million to $88.0 million, down from the previously expected range of $100.0 million to $110.0 million, due primarily to the following factors: 1) our year-to-date revenue results being below our initial expectations; 2) reduced revenue expectations in our Private Exchange business for the remainder of the year due to slower customer adoption of our solutions than originally anticipated; 3) the impact of certain of our Enterprise/Commercial customers transitioning from maintenance of their existing platforms to upgrades to our newest platform on 2016 revenue and 4) the impact of our decision to reduce our focus on the State/Medicaid opportunity.
- Adjusted EBITDA is expected to be in the range of zero to $2.0 million, down from the previously expected range of $10.5 million to $12.0 million due primarily to our reduced revenue guidance and given that our cost structure is comprised of higher fixed costs than variable costs. Of note, the revised guidance includes the impact of approximately $1.8 million of one-time severance, integration and acquisition costs associated with the ConnectedHealth acquisition that either have been incurred to date, or are expected to be incurred by the end of 2016. Adjusted EBITDA differs from GAAP net loss in that it excludes net interest, other expense, taxes, depreciation and amortization expense, adjusted to eliminate stock-based compensation and non-cash charges in fair value of contingent consideration and impairments of goodwill, intangibles and long-lived assets, if any. We are unable to predict with reasonable certainty the ultimate outcome of these exclusions without unreasonable effort. Therefore, we have not provided guidance for GAAP net loss or a reconciliation of the foregoing forward-looking Adjusted EBITDA guidance to GAAP net loss.
Connecture’s management will host a conference call at 5:00 p.m. EDT on Monday, August 8, 2016, to discuss the second quarter 2016 results. The conference call will be accessible by dialing 877-930-8068 and referencing conference ID 55499889. A live webcast of the conference call will also be available on the investor relations section of the Company's website at investors.connecture.com.
Use of Non-GAAP Measures
To provide additional information regarding Connecture’s financial results, Connecture has disclosed in this press release adjusted gross margin and adjusted EBITDA margin, each a non-GAAP financial measure. Connecture defines adjusted gross margin as gross margin before depreciation and amortization expense, as well as stock-based compensation expense. Connecture defines adjusted EBITDA as net income (loss) before net interest, other expense, taxes, depreciation and amortization expense, adjusted to eliminate stock-based compensation and non-cash changes in fair value of contingent consideration and impairments of goodwill, intangible and long-lived assets, if any.
Connecture has included adjusted gross margin and adjusted EBITDA as supplemental financial measures in this press release because they are key measures used by its management and board of directors to understand and evaluate its core operating performance and trends, to prepare and approve its annual budget and to develop short- and long-term operational plans, and because management believes that they provide useful information in understanding and evaluating Connecture’s operating results. However, use of adjusted gross margin and adjusted EBITDA as analytical tools has limitations, and you should not consider them in isolation or as substitutes for analysis of Connecture’s financial results as reported under GAAP. A reconciliation to the closest GAAP measures of these non-GAAP measures is contained in the accompanying tables.
Connecture (NASDAQ:CNXR) is a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual's preferences, health status, preferred providers, medications and expected out-of-pocket costs. Connecture's customers are health insurance marketplace operators such as health plans, brokers and exchange operators, who must distribute health insurance in a cost-effective manner to a growing number of insured consumers. Connecture's solutions automate key functions in the health insurance distribution process, allowing its customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this press release, including statements regarding Connecture’s strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
These forward-looking statements include, among other things, statements about management’s estimates regarding future market growth, revenues and financial performance and other statements about management’s beliefs, intentions or goals. Connecture may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements, and you should not place undue reliance on Connecture’s forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements, including, but not limited to, risks related to (1) Connecture’s ability to manage its growth, including accurately planning and forecasting its financial results and hiring, retaining and motivating employees; (2) the competitive environment for Connecture’s business and the market for Connecture’s solutions; (3) Connecture’s ability to maintain historical contract terms; (4) Connecture’s ability to operate its proprietary software, transition to new platforms and provide innovative and high quality software and services; (5) errors, interruptions or delays in Connecture’s services; (6) breaches of Connecture’s security measures; (7) Connecture’s ability to comply with regulatory requirements; (8) technological and regulatory developments; (9) litigation related to intellectual property and other matters and any related claims, negotiations and settlements; and (10) other risks and potential factors that could affect Connecture’s business and financial results identified in Connecture’s filings with the Securities and Exchange Commission (the “SEC”), including Connecture’s Annual Report on Form 10-K and its quarterly reports on Form 10-Q. The forward-looking statements contained in this press release reflect Connecture’s current views with respect to future events, and Connecture assumes no obligation to update or revise any forward-looking statements except as required by applicable law.
|Condensed Consolidated Statements of Operations and Comprehensive Loss|
|(In thousands, except share and per share data)|
|Three Months Ended |
|Six Months Ended |
|Cost of revenue (1)||13,663||14,019||26,016||25,340|
|Research and development (1)||5,860||6,056||11,364||12,584|
|Sales and marketing (1)||3,092||2,302||5,430||5,185|
|General and administrative (1)||3,273||3,858||6,537||7,463|
|Total operating expenses||12,225||12,216||23,331||25,232|
|Loss from operations||(7,159||)||(2,842||)||(13,061||)||(6,531||)|
|Other expense, net||1,883||1||1,883||9|
|Loss before income taxes||(9,900||)||(4,267||)||(17,211||)||(9,377||)|
|Income tax benefit (provision)||-||8||(25||)||19|
|Net loss per common share:|
|Basic and diluted||$||(0.47||)||$||(0.20||)||$||(0.81||)||$||(0.43||)|
|Weighted-average common shares outstanding:||.|
|Basic and diluted||22,217,696||21,710,951||22,164,984||21,703,483|
|Three Months Ended June 30,||Six Months Ended June 30,|
|(1) Cost of revenue and operating expenses include following stock-based compensation expense:|
|Cost of revenue||$||187||$||277||$||349||$||424|
|Research and development||56||327||243||542|
|Sales and marketing||79||142||195||188|
|General and administrative||277||423||624||732|
|Condensed Consolidated Balance Sheets|
|As of |
June 30, 2016
|As of |
December 31, 2015
|Cash and cash equivalents||$||18,980||$||5,424|
|Accounts receivable - net of allowances||9,769||10,792|
|Prepaid expenses and other current assets||955||652|
|Total current assets||29,704||16,868|
|Property and equipment, net||2,227||2,109|
|Other intangibles, net||12,304||11,392|
|Deferred implementation costs||24,376||24,565|
|Liabilities, redeemable preferred stock and stockholders' deficit|
|Accrued payroll and related liabilities||4,373||3,560|
|Current maturities of debt||2,110||1,441|
|Total current liabilities||48,086||48,091|
|Deferred tax liability||23||23|
|Other long-term liabilities||235||262|
|Redeemable preferred stock||49,936||-|
|Total stockholders' deficit||(47,356||)||(31,180||)|
|Total liabilities, redeemable preferred stock and stockholders' deficit||$||99,157||$||82,689|
|Condensed Consolidated Statements of Cash Flows|
|Six Months Ended|
|Cash flows from operating activities:|
|Adjustments to reconcile net loss to net cash used in operating activities:|
|Depreciation and amortization||2,277||2,550|
|Stock-based compensation expense||1,411||1,886|
|Changes in operating assets and liabilities:|
|Prepaid expenses and other assets||(444||)||277|
|Deferred implementation costs||189||644|
|Accrued expenses and other liabilities||(339||)||999|
|Net cash used in operating activities||(15,468||)||(13,246||)|
|Cash flows from investing activities:|
|Purchases of property and equipment||(643||)||(407||)|
|Business acquisition, net of cash acquired||(4,683||)||-|
|Net cash used in investing activities||(5,326||)||(407||)|
|Cash flows from financing activities:|
|Borrowings of debt||19,706||-|
|Repayments of debt||(33,831||)||(3,802||)|
|Proceeds from Preferred Stock, net||49,286||-|
|Net cash provided by (used in) financing activities||34,350||(4,554||)|
|Net increase (decrease) in cash and cash equivalents||13,556||(18,207||)|
|Cash and cash equivalents - beginning of period||5,424||28,252|
|Cash and cash equivalents - end of period||$||18,980||$||10,045|
|Reconciliation of GAAP to Non-GAAP Measures|
|Three Months Ended |
|Six Months Ended |
|Reconciliation from Gross Margin to Adjusted Gross Margin:|
|Depreciation and amortization||921||952||1,862||1,900|
|Stock-based compensation expense||187||277||349||424|
|Adjusted gross margin||$||6,174||$||10,603||$||12,481||$||21,025|
|Reconciliation from Net Loss to Adjusted EBITDA:|
|Depreciation and amortization||1,092||1,280||2,277||2,550|
|Other expense (income), net||1,883||1||1,883||9|
|Income tax provision (benefit)||-||(8||)||25||(19||)|
|Stock-based compensation expense||599||1,169||1,411||1,886|
|Total net adjustments||$||4,432||$||3,866||$||7,863||$||7,263|
Investor Contact: James Purko Connecture, Inc. firstname.lastname@example.org Phone: 262-432-8210 Media Contact: Matt Schlossberg Amendola Communications for Connecture, Inc. email@example.com Phone: 630-935-9136